A case of carrelizumab-associated immune myocarditis.

Zhao, Lan-Zhen; Liu, Guang; Li, Quan-Fu; Chen, Gang; Jin, Gao-Wa

Zhao, Lan-Zhen; Liu, Guang; Li, Quan-Fu; Chen, Gang; Jin, Gao-Wa.

Afiliación

Zhao LZ; Department of Medical Oncology, Ordos Central Hospital, Ordos, 017000, China.
Liu G; Department of Medical Oncology, Ordos Central Hospital, Ordos, 017000, China.
Li QF; Department of Medical Oncology, Ordos Central Hospital, Ordos, 017000, China.
Chen G; Department of Medical Oncology, Ordos Central Hospital, Ordos, 017000, China.
Jin GW; Department of Medical Oncology, Ordos Central Hospital, Ordos, 017000, China. Electronic address: jingaowa_18@aliyun.com.

Asian J Surg ; 45(1): 496-497, 2022 Jan.

Article en En | MEDLINE | ID: mdl-34629265

Asunto(s)

Miocarditis; Anticuerpos Monoclonales Humanizados/efectos adversos; Humanos; Miocarditis/inducido químicamente; Miocarditis/diagnóstico; Nivolumab

Palabras clave

Adverse reaction; Carrelizumab; Myocarditis; PD-1 inhibitor

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Miocarditis Tipo de estudio: Diagnostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Asian J Surg Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google